This study compared the disintegration times of three immediate-release pain-relief tablets, ibuprofen (200 mg), tramadol HCl (50 mg), and hydrocodone bitartrate-acetaminophen (5 mg/500 mg), in different beverages (milk, calcium-fortified orange juice, commercial iced coffee, and regular Coca-Cola) with those in water using the USP disintegration apparatus. A hybrid medium prepared by blending 640 mL fat-free or 2% milk at 5.0 ± 1.0 °C with 160 mL of 0.1 N hydrochloric acid (HCl) at 39.0 ± 0.5 °C was proposed to better mimic human gastric content after tablet ingestion. The hybrid preparation was then used as the medium in USP dissolution Apparatus 2 to test these pain medications. The results show that the delay of the hydrocodone bitartrate-acetaminophen tablet disintegration in the hybrid media was less extensive than in straight milk (16.46 ± 0.65 min, n = 3 versus 31.94 ± 2.26 min, n = 6 when fat-free milk was used). Significant foam formed in both straight and hybrid fat-free milk. There was less foaming when the same tests were conducted in the USP dissolution apparatus. The ascending and descending motion of a USP disintegration apparatus may facilitate ambient air contact with fat-free milk, resulting in foam formation. If also true in vivo, it reflects a potential problem of hindered drug absorption.
INTRODUCTION
O ral solid dosage forms such as tablets and hard-gelatin capsules, which have been in existence since the nineteenth century, remain the most frequently used dosage forms today. Tablets and capsules accounted for about half of the 579 new medicines licensed from 1995 to 1999 (221 were in tablet dosage form and 51 in capsule form) (1) . A tablet that can withstand the stresses of subsequent packaging operations and reach the patient in an acceptable condition is generally assessed by friability and hardness tests. Disintegration is an important physical property of a tablet dosage form during the research and development stage and is most commonly studied in either water or simulated gastric medium and occasionally in simulated intestinal medium. However, patients do take medications with beverages other than water. Often patients are counseled to take medications, especially pain-relief medications, with milk to decrease the potential for gastric irritation.
Chuong et al. (2) studied the disintegration of TriCor (fenofibrate tablets, 54 mg, Abbott) in different beverages and found that there was a delayed disintegration of TriCor in fat-free milk and 2% milk compared with that in water (19.82 ± 1.82 min and 21.69 ± 0.41 min, respectively, versus 12.06 ± 0.11 min). But TriCor is a lipid-regulating agent. A delay of 7-10 min may not result in a significant clinical impact on the therapeutic outcome. In addition, the delay observed in TriCor disintegration may not occur in other pharmaceutical products because the excipients and formulation procedures are all varied. For example, the bioavailability of ibuprofen, a pain-relief active ingredient, is similar among the different oral dosage forms at approximately 80%, but the time to reach peak concentration differs and is roughly 120 min after tablet administration. Administration of oral products immediately following a meal has a minimal effect on overall bioavailability; however, it decreases the maximal concentration, C max , and the time to reach maximal concentration, T max (3).
Since the pharmaceutical design of an immediaterelease (IR) oral pain medication is expected to release drug substance instantaneously and take action on pain control after ingestion, the in vitro disintegration time is also expected to be short. Therefore, the project had the following objectives: (1) to investigate whether the disintegration time of an IR pain medication tablet in beverages such as milk, commercial iced coffee, calcium-fortified orange juice, or regular Coca-Cola would be the same as in water; (2) to evaluate the effect of simulated food weight on the disintegration time of the model products; and (3) to examine whether a straight beverage was appropriate for conducting such an experiment or a better medium preparation should be proposed and examined. The same medium preparation would then be used to test model drug products in USP dissolution Apparatus 2. 
MATERIALS AND METHODS Materials
Hydrochloric acid (36.5-38.0%) was purchased from VWR. An Acurite timer was obtained from a local store.
Commercial Tablet Model Dosage Forms
Three IR pain-relief tablets were chosen as study products. Tramadol HCl 50-mg tablets (Mylan Pharmaceuticals Inc., Morgantown, WV; Lot: 3000990, Exp. Sep 2009; total tablet weight 188.2 ± 1.8 mg, n = 3), ibuprofen 200-mg tablets (Ivax by Teva, North Wales, PA; Lot: P49749, Exp. Feb 2010; total tablet weight 339.4 ± 3.7 mg, n = 3), and hydrocodone bitartrate-acetaminophen tablets, USP, 5 mg/500 mg (Mallinckrodt Inc., St. Louis, MO; Lot: 0357M64266, Exp. March 2012; total tablet weight 634.1 ± 6.6 mg, n = 3) were purchased from Cardinal Health. Among the three study products, only ibuprofen has an orange/brown colorant coat ( Figure 1 ).
Study Media
Fat-free, 1%, 2%, and 4% milk fortified with vitamins A and D (products of Garelick Farms Inc., Franklin, MA), regular Coca-Cola, and calcium-fortified orange juice (Tropicana Pure Premium, no pulp, Florida) were obtained from two different local stores, while commercial iced coffee was purchased from a local McDonald's restaurant on different occasions.
Methods
Each of the three study pain medication tablets was dropped into one basket tube of the USP disintegration apparatus and loaded into a one-liter, low-form glass beaker filled with 800 mL of 5.0 ± 1.0 °C deionized water (to mimic refrigerated temperature), then lowered into a bath containing 8.5 L of water. The temperature of the bath was maintained at 39.0 ± 1.0 °C throughout the entire test period. The apparatus was calibrated based on the guideline of USP 31-NF 27 (4) to ensure that the basket ascended and descended in an immersion fluid at 29-32 cycles per minute until the tablet was completely disintegrated and fragments fell out of the stainless steel mesh. The disintegration time was then recorded. To study the food-weight effect as a disintegration parameter, the tested pain medication was laid on the mesh of a basket tube. A USP disk weighing 3.05 g was then placed flat on top of the tablet. The experiment was conducted the same as above. In addition to the use of deionized water, fat-free, 1%, 2%, and 4% milk, calcium-fortified orange juice, commercial iced coffee, and regular Coca-Cola were chosen as immersion media to study the beverage effect on tablet disintegration time.
Statistical Analysis
Excel 2000 (Microsoft) was used to manage raw data. Using SigmaPlot 11 Exact Graphs and Data Analysis (Systat Software Inc., San Jose, CA), independent t-test and one-way ANOVA were performed for two-group data and three-group data analysis when normality and equal variance met. A pairwise multiple comparison procedure (Tukey Test) was selected as the posthoc test (5). The rank-sum test and Kruskal-Wallis one-way ANOVA on ranks were chosen for two-group and three-group comparisons when unequal variance existed. Population differences were considered significant at p < 0.05 (5).
RESULTS
All studied pain-relief tablets showed either similar or delayed disintegration in the test beverages in comparison with water. The disintegration times of hydrocodone bitartrate-acetaminophen tablets in whole milk and 2% milk (37.15 ± 2.61 min and 37.75 ± 3.90 min, respectively, n = 6 each) were similar. But they were approximately 6 min longer than the disintegration times of the batches immersed in 1% and fat-free milk (31.64 ± 1.57 min, n = 6 and 31.94 ± 2.26 min, n = 8, respectively). The disintegration times of hydrocodone bitartrate-acetaminophen tablets were shorter in calcium-fortified orange juice, commercial iced coffee, and regular Coca-Cola (27.56 ± 2.32 min, 17.78 ± 0.96 min, and 12.05 ± 1.63 min, respectively) than in milk, but longer than in water (9.99 ± 0.65 min, n = 6, Table 1A and Figure  2A ). Similarity, the disintegration time of ibuprofen tablets in 2% milk was longer than that in water (14.01 ± 1.92 min, n = 6 vs 7.08 ± 1.24 min, n = 3, Table 1B and Figure 2B ). The disintegration time of tramadol HCl tablets was longer in 2% milk (10.42 ± 1.40 min, n = 4), but was similar to that in regular Coca-Cola and in water (7.41 ± 0.88 min, n = 6, and 6.49 ± 0.14 min, n = 3, respectively, Table 1C and Figure 2C ). Disintegration of hydrocodone bitartrate-acetaminophen and ibuprofen tablets in calcium-fortified orange juice was significantly longer than for tramadol HCl tablets (27.56 ± 2.32 min and 21.65 ± 4.29 min vs 4.97 ± 0.49 min, Table 1A -C).
Disintegration of hydrocodone bitartrate-acetaminophen tablets was significantly delayed in milk (21-27 min longer than in water), calcium-fortified orange juice (17.5 min longer than in water), and commercial iced coffee (approximately 8 min longer than in water). But the delay in regular Coca-Cola (2 min longer than in water) would probably not be clinically significant. The delay of ibuprofen tablet disintegration in 2% milk (7 min longer than in water) and in calcium-fortified orange juice (5 min longer than in water) was statistically important, but again, this level of delay will need to be further assessed before claiming clinical significance. The delay of ibuprofen tablet disintegration in commercial iced coffee was significant (14 min longer than in water). For tramadol HCl tablets, disintegration was statistically delayed only in 2% milk.
When a USP disk was applied to simulate the foodweight effect exerted on a tablet ingested after a meal, the data indicate that this effect was more prominent in 2% milk than in 1% milk. In 2% milk, the disintegration times of hydrocodone bitartrate-acetaminophen tablets with and without a USP disk were 37.75 ± 3.90 min (n = 6) and 29.14 ± 0.67 min (n = 3), respectively. But in 1% milk, the differences in disintegration times for hydrocodone bitartrate-acetaminophen tablets with and without a USP disk were smaller (31.64 ± 1.57 min and 29.18 ± 2.29 min, respectively, n = 5 each, Table 2A and Figure 3A) . The disintegration time of hydrocodone bitartrate-acetaminophen tablets without a USP disk was longer in 2% milk than in 1% milk (37.75 ± 3.90 min, n = 6 vs 31.64 ± 1.57 min, n = 5, Table 2A, Figure 3A ), but the times were almost the same when a USP disk was incorporated into the study (29.14 ± 0.67 min, n = 3 vs 29.18 ± 2.29 min, n = 5, Table 2A, Figure 3A ). When a USP disk was applied to an ibuprofen tablet, its disintegration in water was almost the same as that without a disk (7.08 ± 1.24 min and 6.97±0.19 min, respectively, n = 3 each, Table 3B and Figure 3B ), reflecting a prompt drug-release mechanism achieved by the excipients incorporated in the formulation. However, use of a straight beverage as the disintegrating medium might not be appropriate for conducting such an experiment, because normal adults produce up to 60 mL per hour of a basal secretion containing approximately 4 mmol H + . This can rise to more than 200 mL, between 15 and 50 mmol per hour, when maximally stimulated (6) . Because 800 mL of medium in a 1000-mL low-form glass beaker is required to conduct a disintegration study, a hybrid medium of 160 mL of 0.1 N HCl with 640 mL of a test beverage was proposed for this study. To examine how medium temperature equilibrates with water temperature in a bath containing 8.5 L of deionized water maintained at 39.0 ± 0.5 °C, a 1-L beaker holding 160 mL of 0.1 N HCl at 39 °C was placed in the water bath. Six hundred forty milliliters of cold, fat-free milk (6 °C) was poured to the beaker, then a hydrocodone bitartrate-acetaminophen tablet was added to one basket tube, and the USP disintegration apparatus was started. Medium temperature was recorded incrementally until it equilibrated with the water bath temperature. It took 5.5 min to reach 25 °C, 10 min to 30 °C, 25 min to 35 °C, 38 min to 37 °C, and 51 min to 38.2 °C (Figure 4) . The disintegration time of hydrocodone bitartrate-acetaminophen tablets was next tested in the hybrid medium.
Data indicate that although the disintegration times of hydrocodone bitartrate-acetaminophen tablets in the hybrid medium (0.1 N HCl plus 2% or fat-free milk) were longer than those in water, they were not as long as tablet disintegrations in straight 2% or fat-free milk (Table 3 ). The disintegration times of hydrocodone bitartrate-acetaminophen tablets in straight 2% milk and hybrid 2% milk were 37.75 ± 3.90 min (n = 6) and 15.50 ± 1.22 min (n = 3), respectively (P < 0.05). The disintegration times of hydrocodone bitartrate-acetaminophen tablets in straight skim milk and hybrid skim milk were 31.94 ± 2.26 min and mixed with 160 mL 0.1 N HCl) produced foam lasting more than 7 min ( Figures 7A-C ). The foam-formation level for ibuprofen tablets in the fat-free milk 0.1 N HCl hybrid medium was low initially, the first two minutes of the dissolution study, which was also the tablet coating dissolution period ( Figure 8A ). But foam formation was quite notable after the coating layer disappeared and the core tablet disintegrated in the hybrid medium ( Figures 8B  and C) . The question next raised was whether the remarkable foam formation was apparatus-design specific.
To address this question, ibuprofen (a coated tablet) and hydrocodone bitartrate-acetaminophen (an uncoated tablet) were tested in the USP dissolution 16.46 ± 0.65 min, respectively (n = 6 each, P < 0.05, Table 3, Figure 5 ). The disintegration times of hydrocodone bitartrate-acetaminophen tablets were very similar in hybrid 2% milk (15.50 ± 1.22 min, n = 6) and hybrid fat-free milk (16.46 ± 0.65 min, n = 6), as shown in Table 3 and Figure 5 . The disintegration times in the hybrid media were approximately 6 min longer than those in water (9.99 ± 0.65 min, n = 3). This statistical difference may or may not have clinical impact. Of potentially greater clinical significance was the unexpected production of resilient foam in both straight or hybrid fat-free milk throughout the test period of the USP disintegration apparatus (Figures 6-8) . The extent as well as the duration of foam formation are worthy of attention. Hydrocodone bitartrate-acetaminophen tablets churning in 2% and 1% milk produced foam lasting 5 min. Skim milk and 2% milk foam lasted longer than 30 min, and skim milk with 0.1 N HCl foam lasted longer than 15 min ( Figure 6 ). Tramadol tablets churning in hybrid medium (640 mL fat-free milk apparatus with the same hybrid medium preparation (160 mL of 0.1 N HCl at 39 °C blended with 640 mL 2% milk and fat-free milk at 5 °C). The apparatus was operated at 75 rpm, 100 rpm, and 150 rpm. Much less foam formation was observed in the dissolution apparatus (Figure 9 ). Paddle stirring speed did not influence the amount of foam formed in USP Apparatus 2.
DISCUSSION
To our surprise, the three drug products disintegrated in regular Coca-Cola, which contains compressed carbon dioxide, and did not form resilient and sustained bubbles as originally expected; in addition, foam did not form in the commercial iced coffee. Does beverage pH affect the disintegration time of an IR pain medication? Statistical results indicate that disintegration of all three IR pain medications studied (hydrocodone bitartrate-acetaminophen, ibuprofen, and tramadol HCl tablets) was not prolonged significantly in regular Coca-Cola. The results also show that the disintegration times were less consistent in orange juice. Only hydrocodone bitartrate-acetaminophen tablets and ibuprofen tablets showed delayed disintegration in orange juice, but not tramadol HCl.
Hydrocodone bitartrate-acetaminophen tablet disintegration was delayed in all studied beverages except regular Coca-Cola. There was 17.5-min delay of this product in calcium-fortified orange juice, the second most acidic beverage in the study. Combined effects from excipient-beverage interaction and beverage viscosity may account for this observation. During in vitro disintegration studies, fat-free milk exhibited significant foam formation with hydrocodone bitartrate-acetaminophen tablets that lasted for more than 30 min with straight fat-free milk ( Figure 6A ) and more than 15 min with hybrid fat-free milk ( Figure 6C ). Similar foam formation was noted with tramadol tablets (Figure 7 ). If such in vitro behavior correlates in vivo, drug molecule transport to the stomach wall may be hindered. Since little foam was observed initially with ibuprofen tablets until the coating layer dissolved ( Figure 8A ), and the overall foam formation was less ( Figures 8B and 8C) , it was speculated that the coating composition might have functioned as a defoaming agent. The addition of a USP disk to simulate a food-weight effect on the disintegration of an immediate-release tablet revealed that food weight is not an important parameter in such a dosage form because the tablet already has a built-in disintegration mechanism to release drug molecules promptly to alleviate pain. The 0.1 N HCl hybrid fat-free milk exhibited remarkable foam formation with hydrocodone bitartrateacetaminophen and tramadol in the disintegration apparatus for more than 15 min. Raising and lowering the basket of the disintegrating device was speculated to facilitate foam formation by increased air contact with the fat-free milk. Foam was not as significant in USP dissolution Apparatus 2 using fat-free milk and 2% milk whether the paddle was stirred at 75 rpm, 100 rpm, or 150 rpm. 
